InVivoSIM anti-respiratory syncytial virus (RSV) F protein (Nirsevimab Biosimilar)

Clone Catalog # Category
Nirsevimab SIM0088
USD 235 - USD 8140

About InVivoSIM anti-respiratory syncytial virus (RSV) F protein (Nirsevimab Biosimilar)

This non-therapeutic biosimilar antibody uses the same variable regions as the therapeutic antibody Nirsevimab, making it ideal for research use. Nirsevimab is a human IgG1 monoclonal antibody that targets the fusion (F) glycoprotein of respiratory syncytial virus (RSV), a highly contagious virus that causes serious respiratory infections, particularly in infants and older adults. The RSV F protein plays a critical role in viral entry by mediating the fusion of viral and host cell membranes, making it a key target for neutralization. Nirsevimab binds to a highly conserved epitope on the prefusion conformation of the RSV F protein, thereby preventing the conformational changes required for membrane fusion and subsequent infection. Unlike palivizumab, which binds both pre- and postfusion forms, Nirsevimab is specific to the prefusion form, enabling higher potency and prolonged protection. This Nirsevimab biosimilar is ideal for studying RSV entry mechanisms, neutralizing antibody responses, and RSV vaccine or therapeutic development.

InVivoSIM anti-respiratory syncytial virus (RSV) F protein (Nirsevimab Biosimilar) Specifications

IsotypeHuman IgG1, κ
ImmunogenRSV F protein
Reported ApplicationsIn vivo functional assays in vitro functional assays Flow cytometry ELISA
FormulationpH 7.0 Contains no stabilizers or preservatives
Endotoxin
  • ≤0.5EU/mg (≤0.0005EU/μg)
  • Determined by LAL gel clotting assay
Aggregation<5% Determined by SEC
Purity
  • ≥95%
  • Determined by SDS-PAGE
Sterility0.2 μm filtration
ProductionPurified from cell culture supernatant in an animal-free facility
PurificationProtein A
Molecular Weight150 kDa
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze.

The Bio X Cell Singapore website will permanently redirect to https://bioxcell.com/ from 30th April 2026.

This transition is designed to streamline access to new products, product data, technical resources, and provide a smoother ordering experience through our unified global platform.

All products, documentation, and customer support will continue to be available at: https://bioxcell.com/

https://bxcell.sg/ will remain active temporarily to support this transition before redirecting automatically.

Please update your bookmarks to https://bioxcell.com/.

For regional support, please refer to https://bioxcell.com/our-distributors.

For Singapore customers, please contact our authorized distributor, Omnicell Pte Ltd:-

eMail : enquiry@omnicell.com.sg ; Tel : 67470201

Website : www.omnicell.com.sg 

Do not show this again [ CLOSE ]